Hebei Weimiao Biology Co., LTD 1
Location

Nov . 05, 2024 05:54 Back to list

74901-08-9



The chemical compound with the identifier 74901-08-9 is recognized as a specific polymer, often categorized under the broader classification of polyethylene glycol (PEG). This compound has garnered attention in various fields, including pharmaceuticals, cosmetics, and biotechnology, due to its unique properties and versatility.


Polyethylene glycol is a polyether compound that exhibits a range of molecular weights, leading to diverse applications. The particular variant denoted by 74901-08-9 possesses a molecular structure that allows it to function effectively in aqueous solutions, making it an excellent additive for formulations requiring solubility and stability.


One of the prime advantages of using PEG in formulations is its biocompatibility. The non-toxic nature of polyethylene glycol ensures that it can be safely used in medical applications, such as drug delivery systems and topical formulations. Given its ease of modification and ability to enhance the solubility of poorly water-soluble drugs, PEG has become integral in developing new pharmaceutical products. Researchers have found that incorporating PEG into drug formulations can improve the therapeutic efficacy and reduce side effects by enabling controlled release and increasing bioavailability.


In the cosmetics industry, PEG serves multiple functions. Its hygroscopic properties allow it to attract moisture, making it a preferred ingredient in skin-care products that aim to hydrate and protect the skin. Furthermore, PEG can serve as an emulsifier, stabilizing oil and water mixtures, and improving the texture of creams and lotions. Its ability to improve the spreadability of formulations adds to its appeal as a cosmetic ingredient, allowing for a more pleasant user experience.


74901-08-9

74901-08-9

The versatility of a compound like 74901-08-9 is also evident in biotechnology. PEGylation, the process of attaching polyethylene glycol chains to proteins or peptides, is a significant advancement in biopharmaceutical development. This modification can significantly increase the solubility, reduce immunogenicity, and extend the half-life of therapeutic proteins. As a result, PEGylated drugs have been successfully used in the treatment of various conditions, ranging from cancers to chronic diseases.


Environmental considerations are also crucial when discussing polyethylene glycol. While polyethylene glycol is generally regarded as safe, the increasing focus on sustainability in chemical applications prompts ongoing research into the biodegradability of such compounds. Innovations in the synthesis of PEG from renewable resources may pave the way for more environmentally friendly products in the future.


Furthermore, the regulatory landscape surrounding compounds like 74901-08-9 is evolving. Governing bodies, including the FDA and EPA, continually assess the safety and efficacy of chemical substances utilized in consumer products. As a result, manufacturers must stay informed and comply with regulatory updates while also practicing transparency in their ingredient sourcing and formulation practices.


In conclusion, the compound associated with the identifier 74901-08-9 plays a notable role across various industries, significantly impacting how drugs are administered, how cosmetics are formulated, and how proteins are enhanced. Its unique properties, combined with a growing focus on safety and sustainability, are likely to drive further exploration and innovation in its applications. As researchers continue to uncover new uses and methodologies involving PEG, the future appears promising for both the compound itself and the industries that utilize it.


Share
Next：

Latest news

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.


Hit enter to search or ESC to close
orOccitan
en_USEnglish afAfrikaans sqAlbanian amAmharic arArabic hyArmenian azAzerbaijani euBasque belBelarusian bn_BDBengali bs_BABosnian bg_BGBulgarian caCatalan cebCebuano zh_CNChina zh_TWChina (Taiwan) coCorsican hrCroatian cs_CZCzech da_DKDanish nl_NLDutch eoEsperanto etEstonian fiFinnish fr_FRFrench fyFrisian gl_ESGalician ka_GEGeorgian de_DEGerman elGreek guGujarati htHaitian Creole haHausa hawHawaiian he_ILHebrew hi_INHindi hmnMiao hu_HUHungarian is_ISIcelandic igIgbo id_IDIndonesian gaIrish it_ITItalian jaJapanese jvJavanese knKannada kkKazakh kmKhmer rwRwandese ko_KRKorean ckbKurdish kyKyrgyz loLao laLatin lvLatvian lt_LTLithuanian lbLuxembourgish mk_MKMacedonian mgMalgashi ms_MYMalay ml_INMalayalam mtMaltese miMaori mrMarathi mnMongolian my_MMMyanmar ne_NPNepali nb_NONorwegian nyNorwegian psPashto fa_IRPersian pl_PLPolish pt_PTPortuguese pa_INPunjabi ro_RORomanian ru_RURussian smSamoan gdScottish Gaelic sr_RSSerbian stSesotho snShona sdSindhi si_LKSinhala sk_SKSlovak sl_SISlovenian soSomali es_ESSpanish suSundanese swSwahili sv_SESwedish tlTagalog tgTajik ta_INTamil tt_RUTatar teTelugu thThai tr_TRTurkish tkTurkmen ukUkrainian urUrdu ug_CNUighur uz_UZUzbek viVietnamese cyWelsh xhBantu yiYiddish yoYoruba zuZulu orOccitan